AHA Files En Banc Review Petition After 4th Circuit Blocks WV 340B Contract Pharmacy Law — Decision Expected Mid-May
American Hospital Association filed en banc review petition April 17 after 4th Circuit panel blocked West Virginia's S.B. 325 (which forced manufacturers to ship 340B drugs to contract pharmacies).
Combined with the 4th Circuit's April 14 vacatur of Maryland's similar law, drugmakers won two consecutive 4th Circuit rulings. AHA argues panel decision conflicts with 5th and 8th Circuit rulings, citing critical importance of preserving state-level 340B protections.
Decision window typically 30 days. Outcome shapes whether other 4th Circuit states (NC, SC, VA) can pass 340B contract pharmacy access laws — and indirectly affects circuit-split posture for likely Supreme Court review.
Key takeaways
- AHA files en banc petition April 17 — decision typically within 30 days
- Two consecutive 4th Circuit rulings sided with drugmakers (WV + MD)
- Outcome affects whether 4th Circuit states can pass 340B protection laws
- Circuit split deepens — likely Supreme Court review
Primary source
AHASource packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the weekly Intel Brief. Individual sources are always clickable above, no email needed.
This story will move — get the follow-up
The weekly FQHC Intel Brief traces every claim to a primary source, like the one above. Free.
You are signing up for the newsletter you choose, a short welcome sequence, occasional product updates, and one-click unsubscribe. We do not sell your email. Privacy Policy · Do Not Sell/Share
FQHC Talent. (2026, June 30). AHA Files En Banc Review Petition After 4th Circuit Blocks WV 340B Contract Pharmacy Law — Decision Expected Mid-May. Primary source: AHA. Retrieved July 30, 2026, from https://www.fqhctalent.com/intel/aha-en-banc-petition-4th-circuit-340b-wv-april-17-2026
More in Legislation
Jul 24
HHS strips disparate-impact liability out of its Title VI regulations — final rule, effective the day it published, no comment period; 45 CFR part 80 binds every Section 330 grantee
Jul 22
Arkansas AG sues 13 drugmakers + a data firm over 340B — the first time a state goes on OFFENSE under its own 340B shield law, with the state health-center association standing beside him
Jul 16
CY2027 Physician Fee Schedule Proposed Rule Lands — CMS Proposes the FQHC PPS Base Rate Rise to $212.91 (+2.5%), Comments Close September 14
Jul 1
8th Circuit Rejects Novartis's Bid to Block Missouri's 340B Contract-Pharmacy Law — Another State Shield Survives a Manufacturer Challenge